Training device and patient onboarding company Noble International, which was acquired by Aptar Pharma in October 2019, has announced the appointment of Jeffrey Miller as Director, Business Development. The company manufactures training devices that mimic marketed MDIs and DPIs that can simulate actuation force and provide feedback for guiding and correcting inhalation technique.
Miller, who will take responsibility for business development activities for injectables and respiratory devices, rejoins the company after having worked in business development for Gerresheimer’s Pharmaceutical Glass Business Unit. Prior to his position at Gerresheimer, he had been a business development lead at Noble for six years.
Noble CEO Jeff Baker said, “Jeff is an accomplished professional with significant business development experience in the life sciences industry. We are thrilled to welcome him back to the Noble family.”
Read the Noble International press release.
